Clinical Trial Update: Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis

View source ↗

Summary

This clinical trial evaluating clinical remission in early aggressive rheumatoid arthritis has completed; Wyeth is now a subsidiary of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED